ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 71 filers reported holding ALLOVIR INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,951 | +182.7% | 36,256 | +347.0% | 0.00% | – |
| Q2 2023 | $27,577 | -56.6% | 8,111 | -49.7% | 0.00% | – |
| Q1 2023 | $63,576 | -34.6% | 16,136 | -14.8% | 0.00% | – |
| Q4 2022 | $97,137 | +1519.0% | 18,935 | +2214.8% | 0.00% | – |
| Q3 2022 | $6,000 | +50.0% | 818 | -20.7% | 0.00% | – |
| Q2 2022 | $4,000 | -42.9% | 1,032 | +0.3% | 0.00% | – |
| Q1 2022 | $7,000 | -99.2% | 1,029 | -98.4% | 0.00% | – |
| Q4 2021 | $827,000 | -25.1% | 63,905 | +45.1% | 0.00% | – |
| Q3 2021 | $1,104,000 | +209.2% | 44,040 | +143.5% | 0.00% | – |
| Q2 2021 | $357,000 | -78.8% | 18,088 | -74.8% | 0.00% | -100.0% |
| Q1 2021 | $1,680,000 | +15172.7% | 71,828 | +25370.9% | 0.00% | – |
| Q4 2020 | $11,000 | -60.7% | 282 | -72.0% | 0.00% | – |
| Q3 2020 | $28,000 | – | 1,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |